MACROPLASTIQUE IMPLANTS, MPQ-2.5

Agent, Bulking, Injectable For Gastro-urology Use

FDA Premarket Approval P040050 S010

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval to qualify an alternative silicone elastomer material for the macroplastique syringe stopper, as well as an alternative supplier of the syringe stopper (nusil technology, llc at carpinteria, ca. ) there is no change to the indications for use or labeling of the macroplastique device.

DeviceMACROPLASTIQUE IMPLANTS, MPQ-2.5
Classification NameAgent, Bulking, Injectable For Gastro-urology Use
Generic NameAgent, Bulking, Injectable For Gastro-urology Use
ApplicantUROPLASTY, LLC
Date Received2012-10-03
Decision Date2012-12-28
PMAP040050
SupplementS010
Product CodeLNM
Advisory CommitteeGastroenterology/Urology
Supplement TypeNormal 180 Day Track
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address UROPLASTY, LLC 5420 Feltl Road minnetonka, MN 55343

Supplemental Filings

Supplement NumberDateSupplement Type
P040050Original Filing
S012 2019-04-17 Normal 180 Day Track
S011 2014-08-19 30-day Notice
S010 2012-10-03 Normal 180 Day Track
S009
S008 2011-05-02 30-day Notice
S007 2010-11-24 Normal 180 Day Track No User Fee
S006
S005 2010-06-03 30-day Notice
S004 2009-10-23 30-day Notice
S003 2009-02-18 Normal 180 Day Track No User Fee
S002 2007-08-22 Normal 180 Day Track No User Fee
S001 2007-03-02 Normal 180 Day Track No User Fee

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.